We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Florida Contract Manufacturer Gets 483 for Slacking on Testing
Florida Contract Manufacturer Gets 483 for Slacking on Testing
December 6, 2011
Axara Pharmaceuticals has released multiple batches of finished OTC drug products that did not undergo adequate strength and purity testing, according to an FDA Form 483.